[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biovie Inc (BIVI)

Biovie Inc (BIVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,617
  • Shares Outstanding, K 7,544
  • Annual Sales, $ 0 K
  • Annual Income, $ -17,540 K
  • EBIT $ -18 M
  • EBITDA $ -18 M
  • 60-Month Beta 0.72
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.65

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3500 +17.04%
on 04/15/26
1.7800 -11.24%
on 05/01/26
+0.0900 (+6.04%)
since 04/08/26
3-Month
1.0800 +46.30%
on 02/12/26
1.7800 -11.24%
on 05/01/26
+0.4500 (+39.82%)
since 02/06/26
52-Week
1.0600 +49.06%
on 02/05/26
12.3000 -87.15%
on 05/09/25
-10.7200 (-87.15%)
since 05/08/25

Most Recent Stories

More News
BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026

CARSON CITY, Nev., April 27, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and...

BIVI : 1.5800 (+2.60%)
RedChip's Biotech Investor Conference Replays Now Available

ORLANDO, FL / ACCESS Newswire / April 20, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced that on-demand replays...

NXL : 0.3411 (-0.84%)
BIVI : 1.5800 (+2.60%)
SXTP : 1.6000 (+1.27%)
BFRG : 0.6700 (+3.12%)
LTRN : 2.05 (+0.49%)
BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting

CARSON CITY, Nev., April 14, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and...

BIVI : 1.5800 (+2.60%)
RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference

ORLANDO, FL / ACCESS Newswire / April 2, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced its upcoming virtual...

NXL : 0.3411 (-0.84%)
BIVI : 1.5800 (+2.60%)
SXTP : 1.6000 (+1.27%)
BFRG : 0.6700 (+3.12%)
LTRN : 2.05 (+0.49%)
BioVie Announces Abstract Accepted for Presentation at AD/PD 2026

CARSON CITY, Nev., March 12, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and...

BIVI : 1.5800 (+2.60%)
60 Degrees Pharmaceuticals and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESS Newswire / February 27, 2026 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) and BioVie, Inc. (NASDAQ:BIVI) on the RedChip Small Stocks,...

BIVI : 1.5800 (+2.60%)
SXTP : 1.6000 (+1.27%)
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on March 4

CARSON CITY, Nev., Feb. 23, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and...

BIVI : 1.5800 (+2.60%)
New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin America

Commercial Sponsors

SNYR : 0.3875 (-2.05%)
PETV : 0.7805 (unch)
NTHI : 6.85 (+5.55%)
BIVI : 1.5800 (+2.60%)
VTIX : 4.18 (+5.29%)
YYGH : 1.0702 (-4.45%)
SGTM : 0.1500 (+12.78%)
VVOS : 0.6636 (-7.82%)
BioVie Announces Abstracts Accepted for Presentation at the 2026 American College of Psychiatrists Annual Meeting

CARSON CITY, Nev., Feb. 12, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and...

BIVI : 1.5800 (+2.60%)
New to The Street Broadcasts Show #716 Tonight at 6:30 PM ET on Bloomberg Television Featuring Stardust Power (NASDAQ:SDST), BioVie (NASDAQ:BIVI), Roadzen (NASDAQ:RDZN), with Special Segments from Kelsey Grammer on KAREN and Andrew Shaw of 250DAYS.ORG

The show airs as sponsored programming with national television commercials from Synergy CHC, NeOnc Technologies, The Sustainable Green Team (SGTM), Roadzen, and Aeries Technology (AERT)

RDZN : 1.9300 (+3.21%)
SDST : 2.38 (-4.42%)
BIVI : 1.5800 (+2.60%)

Business Summary

BioVie Inc. engages in developing drug therapies for liver disease. The company's product candidate includes BIV201, which are in clinical stage. BioVie Inc. is based in SANTA MONICA, CA.

See More

Key Turning Points

3rd Resistance Point 1.8433
2nd Resistance Point 1.7827
1st Resistance Point 1.6613
Last Price 1.5800
1st Support Level 1.4793
2nd Support Level 1.4187
3rd Support Level 1.2973

See More

52-Week High 12.3000
Fibonacci 61.8% 8.0063
Fibonacci 50% 6.6800
Fibonacci 38.2% 5.3537
Last Price 1.5800
52-Week Low 1.0600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.